USPTO 2015–2025 USPTO PatentsView US Corporation

Vascular Imaging Corporation

USPTO PatentsView assignee record — 15 granted patents across 9 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

15
Total patents granted
9
CPC technology areas
15.1
Avg claims per patent
-100%
5-year filing velocity

Portfolio overview

Vascular Imaging Corporation has been granted 15 US utility patents between 2015 and 2019, placing Vascular Imaging Corporation at rank #19,320 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Vascular Imaging Corporation is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 29.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 15 in the 2015–2019 window — a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Vascular Imaging Corporation's 15.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Vascular Imaging Corporation against peers pursuing similar technology classes.

How does Vascular compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Vascular holds 15 patents — placing it at rank #19,320 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2019

0123456 20152016201720182019 3
USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Vascular Imaging Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 33.3%
2016 1 6.7%
2017 5 33.3%
2018 1 6.7%
2019 3 20.0%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#19,320

Across all tracked assignees

Innovation Score

29.2 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Vascular Imaging Corporation hold?
Vascular Imaging Corporation holds 15 US granted patents filed between 2015 and 2019, spanning 9 technology areas.
What is Vascular Imaging Corporation's Innovation Score?
Vascular Imaging Corporation has an Innovation Score of 29.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Vascular Imaging Corporation focus on?
Vascular Imaging Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 13 patents. The company has filed patents in 9 CPC subclasses total.
Is Vascular Imaging Corporation's patent filing rate increasing or decreasing?
Vascular Imaging Corporation's recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Vascular Imaging Corporation's patents?
Vascular Imaging Corporation's patents average 15.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Vascular Imaging Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope